Cannabidiol
- Generic Name
- Cannabidiol
- Brand Names
- Epidiolex, Sativex, Epidyolex
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30O2
- CAS Number
- 13956-29-1
- Unique Ingredient Identifier
- 19GBJ60SN5
- Background
Cannabidiol, or CBD, is one of at least 85 active cannabinoids identified within the Cannabis plant. It is a major phytocannabinoid, accounting for up to 40% of the Cannabis plant's extract, that binds to a wide variety of physiological targets of the endocannabinoid system within the body. Although the exact medical implications are currently being investig...
- Indication
When used in combination with delta-9-tetrahydrocannabinol as the product Sativex, cannabidiol was given a standard marketing authorization (ie. a Notice of Compliance (NOC)) by Health Canada for the following indications:
...
- Associated Conditions
- Multiple Sclerosis, Seizures, Severe Pain, Moderate Pain
- Associated Therapies
- -
Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- Anne Comi, MD
- Target Recruit Count
- 11
- Registration Number
- NCT04447846
- Locations
- 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States
Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Stero Biotechs Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT04439955
- Locations
- 🇮🇱
Meir Medical Center, Kfar Saba, Israel
A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 90
- Registration Number
- NCT04387617
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Phoenix, Arizona, United States
A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
- First Posted Date
- 2020-02-27
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT04286594
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 75
- Registration Number
- NCT04283019
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients
- Conditions
- Interventions
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- University of Tennessee
- Target Recruit Count
- 68
- Registration Number
- NCT04271917
- Locations
- 🇺🇸
University of Tennessee Health Science Center, Memphis, Tennessee, United States
Cannabidiol for Anxiety
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2020-12-19
- Lead Sponsor
- CB2 Insights
- Registration Number
- NCT04267679
Oral Cannabidiol for Opioid Withdrawal
- Conditions
- Interventions
- First Posted Date
- 2020-01-23
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 3
- Registration Number
- NCT04238754
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 19
- Registration Number
- NCT04231643
- Locations
- 🇺🇸
UC San Diego Medical Center, San Diego, California, United States
Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal
- Conditions
- Interventions
- First Posted Date
- 2019-12-19
- Last Posted Date
- 2020-01-09
- Lead Sponsor
- South West Sydney Local Health District
- Target Recruit Count
- 52
- Registration Number
- NCT04205682
- Locations
- 🇦🇺
Sydney and Sydney Eye Hospital, Sydney, New South Wales, Australia
🇦🇺Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.